Back to results
US 2012/0251542 A1Published application
Anti-toxin vaccine compositions and methods of use thereof
AssigneeRutgers, The State University of New Jersey
InventorsNilgun Tumer, Xiao-Ping Li
Life of this patent
Estimating the term…
Abstract
Compositions and methods for treatment of toxin poisoning are disclosed.
Claims37
A ricin ribosome binding mutant that is altered relative to a wild type ricin A chain toxin of SEQ ID NO:
- 1 at at least two amino acid residues, selected from the group consisting of i) R189A and R234A;
- ii) R193A and R235A;
- iii) R193A and R235A and R189A;
- iv) R193A and R235A and R234A;
- v) R193A and R235A and R189A and R234A;
- and
- vi) R213A and R258A.
4 more elements
A shigella toxin ribosome binding mutant that is altered relative to a wild type Stx1 chain toxin of SEQ ID NO:
- 2 at at least two amino acid residues, selected from the group consisting of
- i) R172A and R176A and R179A;
- ii) R205A and R220A;
- iii) R223A and R248A;
- and
- iv) R251A.
3 more elements
A shigella toxin ribosome binding mutant that is altered relative to a wild type Stx2 chain toxin of SEQ ID NO:
- 3 at at least two amino acid residues, selected from the group consisting of
- i) R172A and R176A and R179A;
- ii) R204A and R219A;
- iii) R222A and R247A;
- iv) R250A.
2 more elements
A method for identifying neutralizing antibodies to ricin comprising
- a) providing a panel of anti-ricin antibodies;
- b) identifying those antibodies which bind specifically to the ribosome binding sequences shown in Table 1, said antibodies being effective to prevent ricin binding to the ribosome, thereby neutralizing the toxicity of ricin.
Dependencies are inferred from the claim text.